IDG WeChat qr Code

Strategic Partnerships

중국에 첫 해외 벤처캐피털 투자를 성공시킨 투자회사로, VC, PE 및 M&A 분야의 글로벌 리더

Trust

펀드 매니저, 정부 및 국부펀드, 연기금, 기관투자자, 재단 및 사학연금 등의 투자파트너 보유

Experience

IDG Capital은 1992년 설립 이래 750개 이상의 중국 및 전 세계 기업에 투자한 경험 축적

Track Record

170회 이상 성공적인 회수 달성, 중국 유니콘 기업의 50% 이상의 초기투자단계에 참여

회사 소개

IDG Capital은 PE, VC 및 M&A 분야에서 축적된 전문성을 통해 투자기업을 최고의 기업으로 성장시키는 것을 지향합니다.

최신뉴스

IDG CAPITAL INVESTS IN CANCER DIAGNOSTICS

CHINA MONEY NETWORK
04.12.2019

IDG Capital joined a $44 million Series B financing round for Creative Biosciences, a Chinese producer of cancer screening and diagnostic kits. The Guangzhou-based company also recently released an early diagnosis kit for colon cancer which the National Medical Products Administration of China approved and licensed in 2018. Creative Biosciences said it is also developing early diagnosis products for lung cancer and bladder cancer tumors. Founded in 2015, Creative Biosciences nod has testing institutes in Guangzhou and Tianjin.

더 보기

IDG CAPITAL-BACKED BIOTECH FIRM RAISES $14.4 MILLION

DEAL STREET ASIA
04.11.2019

EdiGene, a Japanese biotechnology firm that develops genome-editing technologies for therapeutics to treat genetic diseases and cancer, has raised $14.4 million during its Series B round. EdiGene currently has operations in Guangzhou, China and Cambridge, Massachusetts. IDG Capital led EdiGene's Series A funding round in 2018 and also joined another $10 million financing round in 2019.

더 보기
뉴스 전체